Related Experiment Video
Updated: Jan 16, 2026

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry
Published on: November 14, 2025
Integration of elemental imaging and spatial transcriptomic profiling for proof-of-concept metals-based pathway
Aruesha Srivastava1, Neha Shaik2, Yunrui Lu1
1California Institute of Technology, Pasadena, CA 91125, USA.
Abstract:
The complex interplay between metal abundance, transport mechanisms, cell distribution, and tumor progression-related biological pathways (e.g. metabolism, collagen remodeling) remains poorly understood. Traditionally, genes and metals have been studied in isolation, limiting insights into their interactions. Recent advances in spatial transcriptomics and elemental profiling now enable comprehensive exploration of tissue-wide metal-gene interactions, though integration remains challenging. In this proof-of-concept study, we investigated metal-dependent signaling within the tumor microenvironment of a unique colorectal cancer (CRC) tumor. We implemented a spatial multimodal workflow which integrated elemental imaging, gene expression, cellular composition, and histopathological features to uncover metals-related pathways through spatially resolved gene expression correlation analyses. Preliminary findings revealed significant associations, for instance: elevated iron correlated with mesenchymal phenotypes located at the tumor's proliferative front, correlating with expression of genes involved in the epithelial-to-mesenchymal transition pathways, and extracellular matrix remodeling. Preliminary observations from this single sample revealed that high copper concentrations were localized to regions of active tumor growth and were associated with increased expression of immune response genes. This proof-of-concept workflow demonstrates the feasibility of integrating elemental imaging with spatial transcriptomics to identify metals-based gene correlates. Future application of this workflow to larger patient cohorts will pave the way for expansive comparisons across the metallome and transcriptome, ultimately identifying novel targets for tumor progression biomarkers and therapeutic interventions.
Insights
This study reveals how metals like iron and copper influence colorectal cancer (CRC) progression by interacting with genes. Integrating elemental imaging and spatial transcriptomics offers new ways to find cancer biomarkers and therapies.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- The interaction between metal ions and gene expression in cancer is not well understood.
- Traditional methods studying genes and metals in isolation limit insights into their complex interplay.
- Spatial omics technologies offer new avenues for exploring tissue-wide metal-gene interactions.
Purpose of the Study:
- To investigate metal-dependent signaling within the tumor microenvironment of colorectal cancer (CRC).
- To demonstrate a proof-of-concept for integrating elemental imaging with spatial transcriptomics.
- To identify metal-related gene expression patterns associated with tumor progression.
Main Methods:
- Implemented a spatial multimodal workflow integrating elemental imaging, gene expression, and histopathology.
- Performed spatially resolved gene expression correlation analyses to uncover metal-gene associations.
- Analyzed a unique colorectal cancer (CRC) tumor sample.
Main Results:
- Elevated iron levels correlated with mesenchymal phenotypes and epithelial-to-mesenchymal transition (EMT) gene expression at the tumor's proliferative front.
- Iron also showed associations with extracellular matrix remodeling pathways.
- High copper concentrations were found in regions of active tumor growth, linked to increased immune response gene expression.
Conclusions:
- The developed workflow successfully integrates elemental imaging and spatial transcriptomics to identify metal-gene correlates.
- This approach is feasible for uncovering metal-based signaling pathways in the tumor microenvironment.
- Future studies on larger cohorts can identify novel biomarkers and therapeutic targets for colorectal cancer.

